Form 4: Oscar Health President Sells Shares for Tax Obligations

Oscar Health's President, Janet Liang, sold 7,338 shares of Class A Common Stock at a weighted average price of $16.59 per share to cover tax obligations from vested equity awards.

Summary

• Janet Liang, President of Oscar Insurance, reported a sale of Oscar Health, Inc. (OSCR) Class A Common Stock.
• The transaction involved the disposition of 7,338 shares on December 2, 2025.
• The shares were sold at a weighted average price of $16.59 per share, with individual transactions ranging from $16.37 to $16.78.
• The sale was executed under a Rule 10b5-1 plan established on August 8, 2025.
• The purpose of the sale was to satisfy tax withholding obligations arising from the vesting of previously granted equity awards.
• Following this transaction, Janet Liang beneficially owns 172,527 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: The transaction is a routine insider sale for tax purposes, pre-planned under a 10b5-1 plan. While it reduces insider ownership, the reason is administrative and not indicative of a negative outlook, thus having a neutral to slightly positive sentiment due to transparency and compliance.

Positives

• The sale was pre-planned under a Rule 10b5-1 plan, indicating a structured and non-discretionary transaction, which often mitigates concerns about opportunistic insider selling.
• The sale was explicitly for tax withholding obligations, a common and expected event for executives receiving equity compensation.

Negatives

• An insider sale, even for tax purposes, reduces the direct equity stake of a key executive in the company.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction, as it is a report on an individual insider transaction.

Industry Context

Insider sales for tax withholding obligations upon equity award vesting are a routine and common occurrence across all industries, particularly in companies that heavily utilize equity compensation to align executive incentives with shareholder interests. This transaction is consistent with standard practices for managing executive compensation and tax liabilities.

Comparison to Industry Standards

• This transaction is a standard insider sale for tax purposes, a common practice among executives in publicly traded companies across various sectors, including healthcare technology.
• It aligns with typical compensation structures where equity awards vest, triggering tax obligations that are often met by selling a portion of the shares.
• No specific comparable companies or projects are relevant for this type of routine compliance filing.

Related Party Transactions

• The transaction involves a sale of company stock by a key executive (Janet Liang, President of Oscar Insurance), which is a related party transaction in the context of insider reporting.

Stakeholder Impact

• Shareholders: A slight reduction in direct insider ownership, but the pre-planned nature for tax purposes generally mitigates concerns about management's confidence in the company.
• Employees: No direct impact on employees is indicated by this filing.
• Customers: No direct impact on customers is indicated by this filing.
• Suppliers: No direct impact on suppliers is indicated by this filing.
• Creditors: No direct impact on creditors is indicated by this filing.

Key Dates

Recommendation

This Form 4 filing reports a routine insider sale by an executive to cover tax obligations from vested equity awards, executed under a pre-arranged Rule 10b5-1 plan. Such transactions are common and generally not indicative of a change in the company's fundamentals or management's long-term outlook. Therefore, this specific filing does not provide new information that would warrant a change in an existing investment thesis, leading to a 'hold' recommendation based solely on this report.

Keywords

Oscar Health, OSCR, Form 4, Insider Trading, Janet Liang, Stock Sale, Equity Awards, Tax Withholding, Rule 10b5-1, President, Healthcare Technology